Africa Produces 1% of Its Own Medicines. The AfDB Has a Plan to Fix That, and It Starts with Aviation.

The African Development Bank Group presented two interconnected financing platforms to its governors and partners at the 2026 Annual Meetings in Brazzaville on May 28. The Integrated Aviation Transformation Program, known as IATP, and the African Medical Equipment and Medicines Facility, known as AMEF, represent a deliberate shift in how the Bank intends to deploy its balance sheet on continental challenges.

‍

The numbers behind the two initiatives define the problem with precision. Africa manufactures 1% of the medicines it needs and 0.5% of its vaccines. Access delays for essential medicines range from three to nine months. Only 40% of essential medicines reach populations on schedule. In the aviation sector, African regional and national airlines operate only 19% of flights on the continent, with economic losses from that gap estimated at between $50 billion and $100 billion annually. These are not marginal inefficiencies. They are structural absences in continental infrastructure.

‍

The platform approach the Bank is proposing represents a model shift. Multilateral development banks have historically financed individual projects: a hospital here, an airport runway there. The IATP and AMEF are designed differently. They function as shared financing architectures that pool capital from governments, development finance institutions, philanthropic foundations, and private sector actors around common objectives, using the Bank's AAA credit rating to de-risk investment flows that would not otherwise reach the continent.

‍

For the IATP, the target is to mobilise $7 billion over five years to support fleet modernisation, infrastructure upgrades, and market integration for African aviation. Japan announced a $10 million contribution to the IATP's Risk-Sharing Facility at the Brazzaville meetings, a signal of partner confidence in the model's credibility. Nigeria's Minister of Aviation, Festus Keyamo, announced the signing of the first National Compact under the IATP with the Bank, the first country to formally commit to the program's implementation framework.

‍

The link between aviation and medicine is not incidental. Airlines move vaccines, medical equipment, and healthcare personnel. A fragmented aviation market with high costs and poor connectivity constrains the entire medical supply chain. The Bank is explicit that aviation and health are complementary pillars of the same logistics architecture. Fix connectivity and the supply chain for medicines becomes structurally more viable. Fix medicine procurement and the population that benefits from aviation access is healthier and more economically productive.

‍

What distinguishes the platform approach from previous continental health initiatives is the financing architecture. Senegal's Minister of Economy, Abdourahmane Sarr, named risk mitigation as the central challenge and the Bank's AAA credit rating as the catalytic tool. Tanzania's Alternate Governor, Dr. Natu El Maamry Mwamba, cited a Bank guarantee that enabled her country to mobilise half of the $1.2 billion required for a standard-gauge railway project within months. The instrument already works. The question is whether it can be applied at continental scale.

‍

What is not being said as prominently in the official discourse is that the AMEF addresses a vulnerability that the COVID-19 pandemic exposed in stark terms: the continent's almost total dependence on external pharmaceutical supply chains for essential medicines. That exposure is not only a health risk. It is a sovereignty risk. A continent that manufactures 1% of its medicines and 0.5% of its vaccines has very limited capacity to respond to the next pandemic on its own terms. The AMEF is partly a technical solution to procurement inefficiency and partly a response to that deeper structural dependence.

‍

The momentum behind both platforms at the 2026 Annual Meetings was strong. The harder work is implementation. Moving from a financing platform designed to bankable proposals, then to actual deployment, requires national ownership that political cycles and competing budget priorities can erode. The Bank's track record on comparable initiatives will be watched carefully.